GlassScriptPhysician profile
John P Peden
NPI 1265420350
$1,562.48
in general payments reported to CMS, 2019-2025
23 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $126 · 2021: $216 · 2022: $149 · 2023: $22.57 · 2024: $406 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462 · Travel and Lodging: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.44 |
| Travel and Lodging | $160.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $298.94 | 2019-2025 | Gamma, Conextions Tr Tendon Repair System-Implant Mechanism, Swanson |
| Amgen INC. | $220.77 | 2019-2021 | |
| Arthrex, INC. | $184.95 | 2024 | |
| Depuy Synthes Sales INC. | $175.77 | 2019-2025 | Na, Tfn-Advance, Rigidfix |
| Bioventus LLC | $98.09 | 2020-2022 | |
| Smith+Nephew, INC. | $88.82 | 2020-2025 | Pico 14, Renasys Touch, "Acticoat 4"" X 4""" |
| Vericel Corporation | $72.83 | 2020-2024 | Maci |
| Ermi LLC | $70.35 | 2024 | |
| Zimmer Biomet Holdings, INC. | $55.00 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Radius Health, INC. | $42.90 | 2019-2021 | |
| Pacira Therapeutics, INC. | $39.92 | 2019-2021 | |
| Embody, INC. | $32.52 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $30.24 | 2024-2025 | Iovera, Exparel, Zilretta |
| Avanos Medical | $30.07 | 2021-2022 | |
| Fidia Pharma USA INC. | $24.29 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $22.57 | 2023 | Prevena |
| Endo Pharmaceuticals INC. | $17.77 | 2019 | |
| Horizon Therapeutics Plc | $13.98 | 2021 | |
| Checkpoint Surgical, INC | $11.52 | 2020 | |
| Theragen, INC. | $11.02 | 2020 | |
| Medtronic USA, INC. | $10.96 | 2019 | |
| Sonex Health, INC. | $9.20 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$0.05 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Peden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.